LaGRA Trial in Laparoscopic Cholecystectomy
LaGRA
Laparoscopic Guided Regional Analgesia (LaGRA) Reduces Post Operative Pain After Laparoscopic Cholecystectomy - a Randomised, Controlled Trial.
1 other identifier
interventional
76
0 countries
N/A
Brief Summary
This study investigated the effectiveness of a surgeon administered, laparoscopic guided, regional anaesthesia technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2016
Shorter than P25 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2017
CompletedFirst Submitted
Initial submission to the registry
December 15, 2017
CompletedFirst Posted
Study publicly available on registry
January 9, 2018
CompletedJanuary 9, 2018
January 1, 2018
10 months
December 15, 2017
January 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Post operative pain score
Visual analogue pain scores ranging from 0 to 10
6 hours post operatively
Secondary Outcomes (4)
Opioid use
Perioperative period including first 6 hours post operatively
Analgesic use
Perioperative period including first 6 hours post operatively
Readmission rate
30 days post operative
Daycase rates
Day of surgery
Study Arms (2)
LaGRA
EXPERIMENTALregional anaesthesia of the right upper quadrant by injection of levobupivacaine 0.25% to the transversus abdominis plane and the rectus sheath under laparoscopic guidance immediately following specimen removal
Placebo
PLACEBO COMPARATORSham regional anaesthesia of the right upper quadrant by injection of Saline 0.9% to the transversus abdominis plane and the rectus sheath under laparoscopic guidance immediately following specimen removal
Interventions
Levobupivacaine injection to Transversus abdominis plane and rectus sheath
Saline injection to Transversus abdominis plane and rectus sheath
Eligibility Criteria
You may qualify if:
- Patients undergoing laparoscopic cholecystectomy
- ASA I, II or III
You may not qualify if:
- Patients that don't consent to be included
- Allergy to levobupivacaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Surgeon
Study Record Dates
First Submitted
December 15, 2017
First Posted
January 9, 2018
Study Start
October 1, 2016
Primary Completion
July 30, 2017
Study Completion
August 30, 2017
Last Updated
January 9, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share